GC-K impairs the metastatic potential of HCC cell lines under hypoxic conditions and inhibits hypoxia-induced or TNF-α-stimulated expression of the HIF-1α/NF-κB signaling pathway and as well as EMT markers in HCC cells (Zhang F et al., 2021). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.